Experimental drug for advanced solid tumors
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial tests a new drug, SI-B036-ST-101, for people with advanced cancer that has spread or cannot be removed with surgery. It aims to see if the drug is safe and effective for several cancer types, including lung cancer, melanoma, and ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic cancer that has not responded to at least one standard treatment, or for which no standard treatment exists.
- Your cancer is one of the following: non-small cell lung cancer (NSCLC), melanoma, or ovarian cancer (for the expansion part of the trial).
- You have recovered from side effects of previous cancer treatments (side effects are now mild or none).
- Your heart is functioning well, with an ejection fraction of at least 50% (a measure of heart pumping ability).
- Your organ function (like liver and kidneys) is adequate.
- You do not have untreated or active brain metastases, serious heart problems, bleeding issues, or certain lung conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a combination of two experimental medicines in people with advanced or metastatic solid cancers, including non-small cell lung cancer and nasopharyngeal cancer. It aims to see whether the drugs can shrink tumors and improve outcomes, while carefully checking safety and eligibility.
This trial tests a new drug called BI 3810944 for people with advanced solid tumors that haven't responded to standard treatments. It aims to see if the drug is safe and helps shrink tumors.
This trial tests a new drug called IBI363 for people with advanced solid tumors. It aims to see if the drug is safe and effective. You may be able to join if you are generally well and have not had other cancer treatments recently.
This early-stage trial tests a new drug called SI-B036 in patients with advanced cancers that have spread or cannot be completely removed by surgery. The goal is to understand how safe the drug is and how well it works.
This study tests a new drug called SI-B036 for people with advanced breast cancer or other solid tumors that have spread. The goal is to see if the drug is safe and to find the best dose.
This trial tests a new drug called SI-B036 in people with advanced digestive tract or other solid tumors that have spread. It aims to see if the drug is safe and effective. You may qualify if you have a measurable tumor and are in relatively good health.
Hear when a new Locally Advanced/Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.